You are here: Industry Insights > Zydus

News List

Zydus Cadila gets tentative US FDA approval for Brivaracetam tablets expresspharma
June 16, 2021
Zydus Cadila has received tentative approval from the USFDA to market Brivaracetam Tablets, in the strengths of 10 mg, 25 mg, 50 mg, 75 mg, and 100 mg (US RLD: Briviact Tablets). Brivaracetam is used to treat partial-onset of seizures (epilepsy).
Zydus Cadila gets CDSCO nod for clinical trials of antibodies cocktail to treat COVID-19: Sources expresspharma
June 07, 2021
Zydus Cadila has been given permission to conduct clinical trials on neutralising monoclonal antibodies (mAbs)-based cocktail for the treatment of COVID-19 by the Subject Expert Committee (SEC) of Central Drugs Standard Control Organisation (CDSCO) ...
Zydus Cadila gets tentative US FDA nod for Osimertinib Tablets expresspharma
June 04, 2021
Zydus Cadila has received tentative approval from the USFDA to market Osimertinib Tablets in the strengths of 40 mg and 80 mg (US RLD: Tagrisso Tablets). Osimertinib is used to treat lung cancer.
Zydus seeks DCGI nod for clinical trials of monoclonal antibodies cocktail to treat COVID-19 infection expresspharma
May 31, 2021
ZRC-3308 is a cocktail of two monoclonal antibodies targeting two unique epitopes on the spike protein of SARS-CoV-2.
Zydus launches Ujvira (trastuzumab emtansine) for breast cancer treatment expresspharma
May 25, 2021
Zydus Cadila launched Trastuzumab Emtansine, an antibody-drug conjugate (ADC) biosimilar and a drug for treating both early and advanced HER2 positive breast cancer, under the brand name ‘Ujvira’.
Multiples Alternate Asset Management led consortium to acquire Zydus Cadila’s animal health business expresspharma
May 13, 2021
The consortium including Multiples, Canada Pension Plan Investment Board and RARE Enterprises will buy Zydus AH in a $400 million deal.
Zydus Cadila gets final USFDA nod for Macitentan Tablets and eligibility for 180-day shared exclusivity expresspharma
April 09, 2021
Macitentan is used to manage the symptoms of pulmonary arterial hypertension.
Ramp up remdesivir manufacturing to full capacity: Govt to pharma firms expresspharma
April 09, 2021
Mansukh Mandaviya said seven manufacturers - Mylan, Hetero, Jubiliant Life Sciences, Cipla, Dr Reddy's, Zydus Cadila and Sun Pharma - have a monthly production capacity of 31.60 lakh vials.
Zydus seeks DCGI nod for Pegylated Interferon alpha-2b to treat COVID-19 expresspharma
April 06, 2021
91.15 per cent of patients treated with PegIFN were RT PCR negative by day 7 as compared to 78.90 per cent on the standard of care (SOC) arm.
Zydus Cadila, Alembic Pharma recall drugs in US expresspharma
March 31, 2021
Zydus Pharmaceuticals (USA) is recalling four lots of Acyclovir Sodium Injection, 50 mg/mL, 10 mL and 20 mL vials, while Alembic Pharmaceuticals is recalling one lot of Telmisartan tablets, USP, 20 mg.

Previous page 1 2 3 4 5 Next page